| Literature DB >> 30169752 |
Jasper Boeddinghaus1,2,3, Thomas Nestelberger1,3, Raphael Twerenbold1,3,4, Johannes Tobias Neumann4, Bertil Lindahl5, Evangelos Giannitsis6, Nils Arne Sörensen4, Patrick Badertscher1,3, Janina E Jann1,3, Desiree Wussler1,3, Christian Puelacher1,3, Maria Rubini Giménez1,3, Karin Wildi1,3, Ivo Strebel1,3, Jeanne Du Fay de Lavallaz1,3, Farah Selman1, Zaid Sabti1,3, Nikola Kozhuharov1,3, Eliska Potlukova1,2, Katharina Rentsch7, Òscar Miró3,8, F Javier Martin-Sanchez3,9, Beata Morawiec3,10, Jiri Parenica3,11,12, Jens Lohrmann1, Wanda Kloos1, Andreas Buser13,14, Nicolas Geigy15, Dagmar I Keller16, Stefan Osswald1, Tobias Reichlin1,3, Dirk Westermann4, Stefan Blankenberg4, Christian Mueller1,3.
Abstract
Aims: We aimed to evaluate the impact of age on the performance of the European Society of Cardiology (ESC) 0/1h-algorithms and to derive and externally validate alternative cut-offs specific to older patients. Methods and results: We prospectively enrolled patients presenting to the emergency department (ED) with symptoms suggestive of acute myocardial infarction in three large diagnostic studies. Final diagnoses were adjudicated by two independent cardiologists. High-sensitivity cardiac troponin (hs-cTn) T and I concentrations were measured at presentation and after 1 h. Patients were stratified according to age [<55 years (young), ≥55 to <70 years (middle-age), ≥70 years (old)]. Rule-out safety of the ESC hs-cTnT 0/1h-algorithm was very high in all age-strata: sensitivity 100% [95% confidence interval (95% CI) 94.9-100] in young, 99.3% (95% CI 96.0-99.9) in middle-age, and 99.3% (95% CI 97.5-99.8) in old patients. Accuracy of rule-in decreased with age: specificity 97.0% (95% CI 95.8-97.9) in young, 96.1% (95% CI 94.5-97.2) in middle-age, and 92.7% (95% CI 90.7-94.3) in older patients. Triage efficacy decreased with increasing age (young 93%, middle-age 80%, old 55%, P < 0.001). Similar results were found for the ESC hs-cTnT 0/1h-algorithm. Alternative, slightly higher cut-off concentrations optimized for older patients maintained very high safety of rule-out, increased specificity of rule-in (P < 0.01), reduced overall efficacy for hs-cTnT (P < 0.01), while maintaining efficacy for hs-cTnI. Findings were confirmed in two validation cohorts (n = 2767).Entities:
Mesh:
Substances:
Year: 2018 PMID: 30169752 DOI: 10.1093/eurheartj/ehy514
Source DB: PubMed Journal: Eur Heart J ISSN: 0195-668X Impact factor: 29.983